Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics.
European journal of cancer (Oxford, England : 1990)·2015
Elevation in multiple serum inflammatory biomarkers predicts survival of pancreatic cancer patients with inoperable disease.
Journal of gastrointestinal cancer·2014
Skeletal-related events and clinical outcomes in patients with bone metastases and normal levels of osteolysis: exploratory analyses.
Clinical oncology (Royal College of Radiologists (Great Britain))·2012
Cancer treatment-induced bone loss in premenopausal women: a need for therapeutic intervention?
Cancer treatment reviews·2012
Transforming growth-factor-alpha and factor-beta(1) levels in plasma and effusions from patients with cancer or hematologic malignancies.
International journal of oncology·2011
Treatment of dyslipidaemias with fluvastatin.
British journal of clinical practice. Supplement·2009
Lipoprotein(a) as a marker for coronary heart disease.
British journal of clinical practice. Supplement·2009
Fluvastatin for the prevention of restenosis after coronary balloon angioplasty: angiographic and methodological background of the fluvastatin angioplasty restenosis trial.
British journal of clinical practice. Supplement·2009
Risk factor management: the cardiologist's perspective.
British journal of clinical practice. Supplement·2009
Fluvastatin in combination with other lipid-lowering agents.
British journal of clinical practice. Supplement·2009
The patient at risk: who should we be treating?
British journal of clinical practice. Supplement·2009